“We are committed to price transparency across-the-board, and prescription drugs are no different,” said CMS Administrator Seema Verma. “Today’s proposed rule would ensure that those list prices are included in television advertisements, so patients have the information they need to make informed decisions.”
Dr. Barbara L. McAneny, president of the American Medical Association, said, “Although the American Medical Association is opposed to direct-to-consumer advertising of prescription drugs, as long as the practice is allowed, the ads should come with at least a small dose of transparency. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s suggested retail price of those drugs, and we supported similar legislative efforts by Senators Grassley and Durbin earlier this year. While this proposed rule alone won’t remove the often-misleading nature of prescription drug ads, it will give consumers a data point that is currently unavailable. That is a step in the right direction.”
More reading: https://www.healthcarefinancenews.com/news/drug-companies-are-being-required-post-list-prices-television-ads